cilostamide has been researched along with Endolymphatic Hydrops in 1 studies
cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure
Endolymphatic Hydrops: An accumulation of ENDOLYMPH in the inner ear (LABYRINTH) leading to buildup of pressure and distortion of intralabyrinthine structures, such as COCHLEA and SEMICIRCULAR CANALS. It is characterized by SENSORINEURAL HEARING LOSS; TINNITUS; and sometimes VERTIGO.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degerman, E | 1 |
| In 't Zandt, R | 1 |
| Pålbrink, A | 1 |
| Eliasson, L | 1 |
| Cayé-Thomasen, P | 1 |
| Magnusson, M | 1 |
1 other study available for cilostamide and Endolymphatic Hydrops
| Article | Year |
|---|---|
Inhibition of phosphodiesterase 3, 4, and 5 induces endolymphatic hydrops in mouse inner ear, as evaluated with repeated 9.4T MRI.
Topics: Animals; Endolymphatic Hydrops; Female; Humans; Magnetic Resonance Imaging; Mice, Inbred CBA; Phosph | 2017 |